Skip to content

Real world study on diabetes and hypoglycemic medicine and cancer risk based on medical big data

Real world study on diabetes and hypoglycemic medicine and cancer risk based on medical big data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036722
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

case series:Nil

Sponsors

Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 99 Years

Inclusion criteria

Inclusion criteria: (a) aged > 20 years and < 99 years; (b) first diagnosed with type 2 diabetes.

Exclusion criteria

Exclusion criteria: (a) a prior history of cancer; (b) lack of information.

Design outcomes

Primary

MeasureTime frame
cancer incident;

Countries

China

Contacts

Public ContactBin Cui

Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine

cb11302@rjh.com.cn+86 13916743142

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026